PESI score for predicting clinical outcomes in PE patients with right ventricular involvement

Sharon Shalom Natanzon1, Alexander Fardman2, Fernando Chernomordik2

  • 1Cardiovascular Division, Intensive Cardiac Care Unit and Department of Cardiology, Sheba Medical Center, Tel-Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. sharonnatanzon@gmail.com.

Heart and Vessels
|August 22, 2021
PubMed

Insights

The Pulmonary Embolism Severity Index (PESI) effectively predicts adverse outcomes in normotensive patients with right ventricular involvement. Higher PESI scores correlate with increased risk, aiding in better risk stratification for these heterogeneous pulmonary embolism cases.

Area of Science:

  • Cardiology
  • Pulmonology
  • Critical Care Medicine

Background:

  • Pulmonary embolism (PE) with right ventricular (RV) involvement presents a heterogeneous patient group requiring precise risk stratification.
  • Existing risk scores may not fully capture the adverse event potential in normotensive PE patients with RV dysfunction.

Purpose of the Study:

  • To evaluate the efficacy of the Pulmonary Embolism Severity Index (PESI) in predicting adverse clinical outcomes.
  • To compare the predictive performance of PESI against the BOVA score in this specific patient cohort.

Main Methods:

  • A consecutive series of normotensive PE patients with RV involvement were analyzed.
  • Patients were stratified by admission PESI score (≤III vs. ≥IV).
  • Primary outcomes included hemodynamic instability and in-hospital mortality; secondary outcomes encompassed mechanical ventilation, thrombolysis, AKI, and major bleeding. Multivariable logistic regression and C-statistic analysis were employed.

Main Results:

  • The PESI score independently predicted adverse outcomes (HR 4.81, p=0.031), with risk increasing progressively with higher PESI grades (p-trend <0.001).
  • The PESI score demonstrated superior predictive accuracy (AUC=0.746) compared to the BOVA score (AUC=0.679).
  • Twenty percent of patients experienced at least one adverse event, with higher rates observed in intermediate-high risk groups.

Conclusions:

  • The PESI score is a valuable tool for risk stratification in normotensive PE patients with RV involvement.
  • Utilizing PESI aids in identifying patients at higher risk for adverse events, potentially guiding clinical management decisions.

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
75
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
195
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
88